The descriptive epidemiology of epilepsy-a review
By P. N. Banerjee, D. Filippi, W. Hauser. Epilepsy Research, 2009
936 citations recorded by the source corpus.
Epilepsy is a chronic disease experienced by millions and a cause of substantial morbidity and mortality. This review summarizes prevalence and incidence studies of epilepsy that provided a clear definition of epilepsy and could be age-adjusted: requirements if comparisons across studies are to be made. Although few exceptions, age-adjusted prevalence estimates from record-based studies (2.7 to 17.6 per 1000), are lower than those from door-to-door surveys (2.2 to 41.0 per 1000). Age-adjusted incidence ranged from 16 to 51 per 100,000, with one exception in Chile, where incidence was 111 per 100,000. Variation in reported prevalence and incidence may be related to factors such as access to health care, regional environmental exposures, or socioeconomic status. A higher proportion of epilepsy characterized by generalized seizures was reported in most prevalence studies. Epilepsy characterized by partial seizures accounted for 20% to 66% of incident epilepsies. Virtually all prevalence and incidence studies report a preponderance of seizures of unknown cause. Additional prevalence studies are needed in regions where data does not exist, and additional incidence studies in all regions. Interpretation of differences in prevalence and incidence will require understanding of the role of cultural, social and economic factors influencing epilepsy and its care.
Subfields: Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/32a60e1439e00e3a9924a2b601845abd3834f274
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- K. Laxer
- Lawrence J. Hirsch
- K. Fiest
- N. Jetté
- E. Trinka
- J. Langfitt
- K. Sauro
- F. Cendes
Citations in the corpus
- Prevalence and incidence of epilepsy (2017, background): “The trend in the point prevalence of active epilepsy by 10year age groups is consistent with previous reports.(35) Prevalence is expectedly lowest early in life, increasing to its highest level during adolescence and early adulthood, decreases after age 30, and remains fairly constant for the remain”
- The consequences of refractory epilepsy and its treatment. (2014, background): “The prevalence of epilepsy in developed countries ranges between 4 and 10 per 1,000 individuals per year [2,20,21], with much greater prevalence rates in developing and resource-poor countries [2], and some estimates at greater than 130 per 1000 individuals per year [3,24].”
- Cost of disorders of the brain in Europe 2010. (2011, neutral): “The worldwide annual incidence of epilepsy ranges from 16 to 51 per 100,000 (Banerjee et al., 2009).”